Icon (ICLR) Competitors $180.01 +2.17 (+1.22%) Closing price 04:00 PM EasternExtended Trading$180.02 +0.00 (+0.00%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TMO, WCN, TCOM, RDDT, CPAY, TOST, and AERShould you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Waste Connections (WCN), Trip.com Group (TCOM), Reddit (RDDT), Corpay (CPAY), Toast (TOST), and Aercap (AER). Icon vs. Its Competitors Medpace Charles River Laboratories International IQVIA Thermo Fisher Scientific Waste Connections Trip.com Group Reddit Corpay Toast Aercap Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends. Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.82%10.95%6.23% Which has more volatility & risk, MEDP or ICLR? Medpace has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Do insiders and institutionals hold more shares of MEDP or ICLR? 78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate MEDP or ICLR? Medpace currently has a consensus target price of $412.73, suggesting a potential downside of 14.23%. Icon has a consensus target price of $219.64, suggesting a potential upside of 22.02%. Given Icon's stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Icon 0 Sell rating(s) 6 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.76 Which has stronger valuation & earnings, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.23B6.06$404.39M$13.4535.78Icon$8.28B1.76$791.47M$9.7218.52 Does the media favor MEDP or ICLR? In the previous week, Medpace had 21 more articles in the media than Icon. MarketBeat recorded 28 mentions for Medpace and 7 mentions for Icon. Medpace's average media sentiment score of 1.46 beat Icon's score of 1.03 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 21 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Icon News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricIconMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.54B$7.67B$5.75B$9.83BDividend YieldN/A2.66%6.66%4.49%P/E Ratio18.5278.6782.4426.63Price / Sales1.7646.62530.43110.53Price / Cash8.8824.8225.7028.92Price / Book1.5219.5910.646.56Net Income$791.47M$242.04M$3.28B$266.04M7 Day Performance3.45%-0.73%-0.08%-0.58%1 Month Performance8.15%4.61%10.36%6.24%1 Year Performance-42.35%9.15%49.00%22.21% Icon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRIcon3.7818 of 5 stars$180.01+1.2%$219.64+22.0%-44.8%$14.54B$8.28B18.5241,900News CoveragePositive NewsAnalyst ForecastGap UpMEDPMedpace4.5366 of 5 stars$466.80+0.7%$406.60-12.9%+33.2%$13.03B$2.11B34.715,900Positive NewsAnalyst DowngradeCRLCharles River Laboratories International3.5377 of 5 stars$164.03+1.4%$175.69+7.1%-18.4%$7.96B$4.05B-123.3320,100Short Interest ↑Analyst RevisionIQVIQVIA4.8939 of 5 stars$188.08-1.6%$228.62+21.6%-26.9%$32.50B$15.41B27.2288,000Positive NewsAnalyst ForecastTMOThermo Fisher Scientific4.9235 of 5 stars$490.73-1.9%$593.00+20.8%-20.9%$188.80B$42.88B28.38125,000Positive NewsAnalyst ForecastInsider TradeWCNWaste Connections4.8297 of 5 stars$182.36-1.3%$215.00+17.9%-2.0%$47.75B$9.23B73.5323,854Positive NewsTCOMTrip.com Group3.8593 of 5 stars$65.93+1.6%$77.25+17.2%+51.9%$42.41B$7.30B19.1141,073RDDTReddit3.2446 of 5 stars$219.96+1.2%$175.38-20.3%+266.6%$40.67B$1.30B199.962,233Positive NewsGap UpCPAYCorpay4.1671 of 5 stars$322.67-2.6%$399.43+23.8%+0.7%$23.39B$3.97B21.9211,200Positive NewsTOSTToast3.8391 of 5 stars$43.42-1.3%$45.54+4.9%+76.3%$22.44B$4.96B127.715,700Positive NewsShort Interest ↓AERAercap2.9698 of 5 stars$120.48+0.9%$122.57+1.7%+27.9%$22.31B$8.00B7.49740News CoveragePositive News Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TMO Alternatives WCN Alternatives TCOM Alternatives RDDT Alternatives CPAY Alternatives TOST Alternatives AER Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.